Search Results

World Orphan Drug Congress Europe 2024 22 – 25 October | Fira De Barcelona Montjuic Join thousands of industry leaders at Europe’s leading orphan drug and rare disease congress. World Orphan Drug Congress covers the start-to-finish of orphan drugs; from regulation & policy to global pricing and gene therapies. Register with code OPHTH20 to save […]

Dry eye disease (DED) is a multifactorial condition of the ocular surface and tears. It is frequently encountered in ocular practices, comprising nearly 33% of visits in the USA, and with an estimated global prevalence ranging between 5% and 50%.1,2 The chronic symptoms and discomfort reported by patients with DED directly impact their quality of life […]

It was a pleasure to catch up with our Editorial Board member, Dr David Chang (University of California, San Francisco, CA, USA) who gave us his highlights from this year’s meeting, including the annual film festival. David Chang was speaking at the American Society of Cataract and Refractive Surgery, 5–8 May, 2023. Question: What were your […]

Maximizing the potential for patient satisfaction, following cataract surgery, can be enhanced through the use of machine learning. Dr Mark Packer (Packer Research Associates, Inc., Boulder, CA, USA) talks to touchOPHTHALMOLOGY about the implications of artificial intelligence in gathering patient feedback and follow-up data. The presentation entitled ‘Predicting Vision Outcomes in Cataract Surgery with Machine […]

Artificial intelligence has huge potential to help cataract surgeons in the area of patient selection. Dr Mark Packer (Packer Research Associates, Inc., Boulder, CA, USA) gave us his insight into how machine learning can be applied in cataract treatment, to improve patient outcomes. The presentation entitled ‘Predicting Vision Outcomes in Cataract Surgery with Machine Learning’ […]

Identifying treatments that prevent diabetic retinopathy progression is a priority in current research. Patients with non-proliferative retinopathy currently have limited treatment options to prevent the progression of retinopathy and loss of vision, and therapies such as anti–vascular endothelial growth factor (VEGF) therapy, steroid injectable therapy and laser treatment are reserved for patients who advance to proliferative diabetic retinopathy or diabetic macular oedema (DMO). The […]

We were delighted to speak with Dr Mitchell A Jackson (Jacksoneye, Lake Villa, IL, USA) on his views about the main challenges faced by ophthalmic surgeons today, and common reasons for IOL exchange. Questions: 1. What are the biggest challenges facing ophthalmologic surgeons today? (0:19) 2. What are the most common reasons for intraocular lens […]